Statement of Principles concerning osteogenesis imperfecta (Reasonable Hypothesis) (No. 53 of 2023)

Administered by Department of Veterans' Affairs

Legislation au F2023L00502 In force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

STATEMENT OF PRINCIPLES CONCERNING

OSTEOGENESIS IMPERFECTA

(REASONABLE HYPOTHESIS) (NO. 53 OF 2023)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Statement of Principles concerning osteogenesis imperfecta (Reasonable Hypothesis) (No. 53 of 2023).

Background

2.             The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), repeals Instrument No. 35 of 2015 (Federal Register of Legislation No. F2014L01848) determined under subsection 196B(2) of the VEA concerning osteogenesis imperfecta.

3.             The Authority is of the view that there is sound medical-scientific evidence that indicates that osteogenesis imperfecta and death from osteogenesis imperfecta can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(2) of the VEA a Statement of Principles concerning osteogenesis imperfecta (Reasonable Hypothesis) (No. 53 of 2023).  This Instrument will in effect replace the repealed Statement of Principles.

Purpose and Operation

4.             The Statement of Principles will be applied in determining claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

5.             The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

before it can be said that a reasonable hypothesis has been raised connecting osteogenesis imperfecta or death from osteogenesis imperfecta, with the circumstances of that service.  The Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

6.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 10 MAY 2022 concerning osteogenesis imperfecta in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

7.             The contents of this Instrument are in similar terms as the repealed Instrument.  Comparing this Instrument and the repealed Instrument, the differences include:

  • adopting the latest revised Instrument format, which commenced in 2015;
  • specifying a day of commencement for the Instrument in section 2;
  • revising the definition of 'osteogenesis imperfecta' in subsection 7(2);
  • including ICD-10-AM codes for 'osteogenesis imperfecta' in subsection 7(3);
  • revising the reference to 'ICD-10-AM code' in subsection 7(4);

 

Consultation

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to osteogenesis imperfecta in the Government Notices Gazette of 10 MAY 2022, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority in relation to the investigation.

Human Rights

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

10.         The determining of this Instrument finalises the investigation in relation to osteogenesis imperfecta as advertised in the Government Notices Gazette of 10 MAY 2022.

References

11.         A list of references relating to the above condition is available on the Authority's website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 53 of 2023

Kind of Injury, Disease or Death: Osteogenesis imperfecta

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(2) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have osteogenesis imperfecta;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting osteogenesis imperfecta with the circumstances of eligible service rendered by a person, as set out in clause 5 of the Explanatory Statement;
  • replaces Instrument No. 35 of 2015; and
  • reflects developments in the available sound medical-scientific evidence concerning osteogenesis imperfecta which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICESCR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICESCR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Statement of Principles concerning osteogenesis imperfecta (Reasonable Hypothesis) (No. 53 of 2023) was determined by the Repatriation Medical Authority (the Authority) under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). This instrument was introduced to address the need for updated medical-scientific evidence regarding the connection between osteogenesis imperfecta and military service, replacing the previous Statement of Principles from 2015. The Authority determined this Statement of Principles following an investigation into the latest available evidence, which concluded that osteogenesis imperfecta and death from osteogenesis imperfecta can be related to specific kinds of service. The Statement of Principles outlines the minimum factors that must exist and be related to the service for a reasonable hypothesis to be raised, facilitating claims and assessments under both the VEA and the MRCA. The instrument also ensures compatibility with human rights, promoting the rights of veterans, current and former Defence Force members, and their dependents by ensuring fair, proportionate, and transparent access to social security and health benefits. The purpose of this Legislative Instrument is to improve the quality of medico-scientific outcomes under the VEA and the MRCA by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons with osteogenesis imperfecta. It also facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal. The instrument reflects the latest medical-scientific evidence concerning osteogenesis imperfecta, ensuring that the qualifying conditions for benefits are reasonable, proportionate, and transparent, thereby promoting various human rights including the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health.

Scope and Application

The Statement of Principles concerning osteogenesis imperfecta (Reasonable Hypothesis) (No. 53 of 2023) applies to veterans, current and former Defence Force members, and other persons such as their dependents who are eligible for benefits under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). This legislation facilitates the assessment and determination of claims related to osteogenesis imperfecta by setting out the minimum factors that must exist for a reasonable hypothesis to be raised connecting osteogenesis imperfecta or death from osteogenesis imperfecta with service rendered by a person. It applies to specific kinds of service including operational, peacekeeping, hazardous, British nuclear test defence, warlike, and non-warlike service. The Instrument is designed to replace the previously repealed Statement of Principles and reflects the latest sound medical-scientific evidence concerning osteogenesis imperfecta. The Authority has ensured that this Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments, thereby promoting the rights of veterans and Defence Force members without discrimination. The scope of this Act extends to Commonwealth legislation, specifically under the VEA and the MRCA, and it does not introduce any new exclusions or exemptions. The Authority has determined that this Instrument is a technical one that improves the medico-scientific quality of outcomes under these Acts. The Repatriation Medical Authority undertook an investigation and invited submissions from relevant parties, although no submissions were received for consideration. This Statement of Principles, once determined, finalises the investigation concerning osteogenesis imperfecta, ensuring that the assessment of claims is based on the latest available evidence.

Key Provisions

The Statement of Principles concerning osteogenesis imperfecta (Reasonable Hypothesis) (No. 53 of 2023) (the Instrument) sets out the specific factors that must exist to establish a connection between osteogenesis imperfecta or death from osteogenesis imperfecta and service rendered by a person in particular kinds of service (section 4). For the purposes of the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA), these kinds of service include operational, peacekeeping, hazardous, and British nuclear test defence service under the VEA, and warlike and non-warlike service under the MRCA (section 5). This Instrument is determined under subsection 196B(2) of the VEA to replace Instrument No. 35 of 2015 (section 2). The Instrument imposes obligations on the Repatriation Medical Authority to ensure that it has considered the latest sound medical-scientific evidence in determining the factors that must exist to connect osteogenesis imperfecta or death from osteogenesis imperfecta with the service rendered by a person (section 6). It also requires the Authority to facilitate claimants in making and assessing claims under the VEA and the MRCA, as well as the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal (section 2). Additionally, the Instrument must be compatible with the human rights and freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011 (section 9). Breaches of the obligations imposed by the Instrument may lead to civil or criminal consequences. For example, if the Repatriation Medical Authority fails to consider the latest sound medical-scientific evidence or does not facilitate claimants in making and assessing claims, it may be subject to legal action by affected parties. The penalties for such breaches would depend on the specific nature of the breach and the applicable laws. It is important to note that the Instrument itself does not outline specific penalties for breach, but rather establishes the obligations and requirements for the Repatriation Medical Authority. In conclusion, the Statement of Principles concerning osteogenesis imperfecta (Reasonable Hypothesis) (No. 53 of 2023) sets out the factors that must exist to connect osteogenesis imperfecta or death from osteogenesis imperfecta with service rendered by a person in particular kinds of service. It imposes obligations on the Repatriation Medical Authority to consider the latest sound medical-scientific evidence and facilitate claimants in making and assessing claims under the VEA and the MRCA. Breaches of these obligations may lead to civil or criminal consequences, although the specific penalties would depend on the nature of the breach and the applicable laws.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Statement of Principles
Concepts
Definitions & Interpretation
Regulatory Standards
Consultation Requirements

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.